1) experimental autoimmune myasthenia gravis (EAMG)
实验性自身免疫性重症肌无力(EAMG)
2) EAMG
实验性自身免疫重症肌无力(EAMG)
3) oEAMG
实验性自身免疫性眼肌型重症肌无力
1.
Objective: To establish a novel model of ocular experimental autoimmune myasthenia gravis (oEAMG) in HLA-DQ8 transgenic mice and study the immunologic pathogenesis of oEAMG .
目的： 利用HLA—DQ8转基因小鼠建立实验性自身免疫性眼肌型重症肌无力(oEAMG)模型，并探讨oEAMG免疫学发病机制。
4) Experimental autoimmune myasthenia gravis
实验性自身免疫性重症肌无力
1.
Treatment of experimental autoimmune myasthenia gravis by nasal tolerance with a recombinant fragment of acetylcholine receptor conjugated to cholera toxin B subunit;
与霍乱毒素B亚单位结合的重组人AChR片断经鼻腔治疗实验性自身免疫性重症肌无力
2.
Objective To investigate the effect of anti-acetylcholine receptor monoclonal antibody A7 in experimental autoimmune myasthenia gravis (EAMG).
目的探讨抗乙酰胆碱受体单克隆抗体A7(抗AChRmAbA7)对实验性自身免疫性重症肌无力(EAMG)的作用。
3.
Objective:To investigation the effect of anti-acetylcholine receptor monoclonal antibody A7 in experimental autoimmune myasthenia gravis (EAMG) .
目的:探讨抗乙酰胆碱受体单克隆抗体A7(Anti-AChR mAb A7)对实验性自身免疫性重症肌无力(EAMG)的作用。
5) experimental autoimmune myositis
实验性自身免疫性肌炎
1.
The role of CD28 in experimental autoimmune myositis and response to tripterygium wilfordii polycoside treatment;
雷公藤多甙对CD28在实验性自身免疫性肌炎发病中作用的影响
2.
Objective:To study the expression of tumor necrosis factor-related apoptosis inducing ligand(TRAIL)and its receptors in muscle tissues of experimental autoimmune myositis(EAM) model in rats.
目的:分析肿瘤坏死因子相关凋亡诱导配体(TRAIL)及其受体在实验性自身免疫性肌炎(EAM)动物模型骨骼肌组织中的表达情况,研究TRAIL系统在特发性炎性肌病(IIM)发病机制中的作用和意义。
6) Experimental Autoimmune Myasthenia Gravis
实验性重症肌无力
1.
A Study of Immunotherapy and Immunomodulation Mechanism in the Treatment of Experimental Autoimmune Myasthenia Gravis by RelB-Silenced DC
RelB基因沉默DC对实验性重症肌无力的治疗作用及免疫调节机制研究
补充资料：家族性阵发性肌张力不全性舞蹈手足徐动症
家族性阵发性肌张力不全性舞蹈手足徐动症
familial paroxysmal myoclystonia choreoathetosis
系阵发性肌张力不全性舞蹈手足徐动症的一种类型。常染色体显性遗传，起病于婴儿期，有阵发性舞蹈手足徐动和肌张力不全运动，发作持续多在1小时以上，无意识障碍，脑电图正常。发病机制不明。用抗癫痫药物有效。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条